While NF-κB has been reported to be a key factor regulating a number of genes that are crucial for tumor invasion and metastasis, parthenolide is considered a potential antitumor therapeutic drug that functions by inhibiting the NF-κB signaling pathway [101]. This evidence concerns the gene NFKB1 and neoplasm.